相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F. Garrelfs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Chemical strategies for strand selection in short-interfering RNAs
Andrew J. Varley et al.
RSC ADVANCES (2021)
Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells
Andrew J. Varley et al.
NUCLEIC ACID THERAPEUTICS (2020)
Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs
Venubabu Kotikam et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
Synthesis and Evaluation of Neutral Phosphate Triester Backbone-Modified siRNAs
Kouta Tsubaki et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo
Annabelle Biscans et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Current Development of siRNA Bioconjugates: From Research to the Clinic
Ivan Chernikov et al.
FRONTIERS IN PHARMACOLOGY (2019)
Selective Transesterification of 2,2,2-Trifluoroethyl Phosphates: Synthesis of Mixed Unsymmetrical Phosphates
Kouta Tsubaki et al.
ORGANIC LETTERS (2019)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Conjugation and Evaluation of Small Hydrophobic Molecules to Triazole-Linked siRNAs
Brandon J. Peel et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications
Bryan R. Meade et al.
NATURE BIOTECHNOLOGY (2014)
Amides are excellent mimics of phosphate internucleoside linkages and are well tolerated in short interfering RNAs
Daniel Mutisya et al.
NUCLEIC ACIDS RESEARCH (2014)
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Fritz Eckstein
NUCLEIC ACID THERAPEUTICS (2014)
Multiple sensors ensure guide strand selection in human RNAi pathways
Cameron L. Noland et al.
RNA (2013)
Steric Restrictions of RISC in RNA Interference Identified with Size-Expanded RNA Nucleobases
Armando R. Hernandez et al.
ACS CHEMICAL BIOLOGY (2012)
Efficient synthesis and cell-based silencing activity of siRNAS that contain triazole backbone linkages
Tim C. Efthymiou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Evaluation of siRNAs that contain internal variable-length spacer linkages
Tim C. Efthymiou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook
Siddharth Shukla et al.
CHEMMEDCHEM (2010)
Phosphorothioate-Stimulated Cellular Uptake of siRNA: A Cell Culture Model for Mechanistic Studies
A. Detzer et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Chemical Modification of siRNAs for In Vivo Use
Mark A. Behlke
OLIGONUCLEOTIDES (2008)
Molecular basis for target RNA recognition and cleavage by human RISC
Stefan Ludwig Ameres et al.
CELL (2007)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
RNA interference in mammalian cells by chemically-modified RNA
DA Braasch et al.
BIOCHEMISTRY (2003)
分享论文
